 BETHESDA, Md., Sept. 02, 2021 GLOBE NEWSWIRE -- Gain Therapeutics, Inc. Nasdaq: GANX Gain, or the Company, a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually from September 13th - 15th. 